Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum

European Journal of Neuroscience

Volumn 15, Issue 4, 2002, Pages 713-720

  Bubser, Michael ^a   Deutch, Ariel Y ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Psychiatric Hospital at Vanderbilt   (United States)

Author keywords

Clozapine; Fos; Haloperidol; Rat

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DIZOCILPINE; HALOPERIDOL; OLANZAPINE; RACLOPRIDE; RISPERIDONE; ZIPRASIDONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; EXTRAPYRAMIDAL SYMPTOM; GENE EXPRESSION; HISTOCHEMISTRY; INCIDENCE; MALE; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; NERVE CELL; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SYMPTOM;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DYSKINESIA, DRUG-INDUCED; EXCITATORY AMINO ACID ANTAGONISTS; HALOPERIDOL; MALE; MUSCARINIC ANTAGONISTS; NEOSTRIATUM; NEURONS; NEUROPIL; PROTO-ONCOGENE PROTEINS C-FOS; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROTRANSMITTER; SEROTONIN ANTAGONISTS;

EID: 0036460115     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2002.01903.x     Document Type: Article

References (57)

1. Aosaki, T., Kimura, M. & Graybiel, A.M. (1995) Temporal and spatial characteristics of tonically active neurons of the primate's striatum. J. Neurophysiol., 73, 1234-1252.
2. Arnt, J. & Skarsfeldt, T. (1998) Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology, 18, 63-101.
3. Arvidsson, U., Riedl, M., Chakrabarti, S., Lee, J.H., Nakano, A.H., Dado, R.J., Loh, H.H., Law, P.Y., Wessendorf, M.W. & Elde, R. (1995) Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci., 15, 3328-3341.
4. Bernard, V., Levey, A.I. & Bloch, B. (1999) Regulation of the subcellular distribution of m4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: Evidence for regulation of cell surface receptors by endogenous and exogenous stimulation. J. Neurosci., 19 , 10237-10249.
5. Berretta, S., Parthasarathy, H.B. & Graybiel, A.M. (1997) Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci., 17, 4752-4763.
6. Boegman, R.J. & Vincent, S.R. (1996) Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse, 22, 70-77.
7. Bolam, J.P., Hanley, J.J., Booth, P.A. & Bevan, M.D. (2000) Synaptic organisation of the basal ganglia. J. Anat., 196, 527-542.
8. Bubser, M. & Deutch, A.Y. (2000) Differential effects of typical and atypical antipsychotic drugs on Fos protein expression in striatal patch and matrix compartments. Soc. Neurosci. Abstr., 26, 1487.
9. Bubser, M., Stanley, C.M. & Deutch, A.Y. (1999) Differential actions of typical and atypical antipsychotic drugs on striatal patch and matrix compartments. Schizophr. Res., 36, 62.
10. Canales, J.J. & Graybiel, A.M. (2000) A measure of striatal function predicts motor stereotypy. Nature Neurosci., 3, 377-383.
11. Chesselet, M.F. & Graybiel, A.M. (1986) Striatal neurons expressing somatostatin-like immunoreactivity: Evidence for a peptidergic interneuronal system in the cat. Neuroscience, 17, 547-571.
12. Coughenour, L.L. & Cordon, J.J. (1997) Characterization of haloperidol and trifluperidol as subtype-selective N-methyl-D-aspartate (NMDA) receptor antagonists using [3H]TCP and [3H]ifenprodil binding in rat brain membranes. J. Pharmacol. Exp. Ther., 280, 584-592.
13. Delfs, J.M., Anegawa, N.J. & Chesselet, M.F. (1995) Glutamate decarboxylase messenger RNA in rat pallidum: comparison of the effects of haloperidol, clozapine and combined haloperidol-scopolamine treatments. Neuroscience, 66 , 67-80.
14. Deutch, A.Y. (1996) Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. In Csernansky, J.G. (ed.), Antipsychotics. Springer, Berlin, pp. 117-161.
15. Deutch, A.Y., Lee, M.C., Gillham, M.H., Cameron, D.A., Goldstein, M. & Iadarola, M.J. (1991) Stress selectively increases Fos protein in dopamine neurons innervating the prefrontal cortex. Cereb. Cortex, 1, 273-292.
16. Deutch, A.Y., Lee, M.C. & Iadarola, M.J. (1992) Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol. Cell. Neurosci., 3, 332-341.
17. Deutch, A.Y., Lewis, D.A., Whitehead, R.E., Elsworth, J.D., Iadarola, M.J., Redmond, D.E. Jr & Roth, R.H. (1996) Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate. Synapse, 23, 182-191.
18. Dragunow, M., Robertson, G.S., Faull, R.L., Robertson, H.A. & Jansen, K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience, 37, 287-294.
19. Fatemi, H.S., Meltzer, H.Y. & Roth, B.L. (1996) Atypical antipsychotic drugs: clinical and preclinical studies. In Csernansky, J.G. (ed.), Antipsychotics. Springer, Berlin, pp. 77-115.
20. Fink-Jensen, A., Ludvigsen, T.S. & Korsgaard, N. (1995) The effect of clozapine on Fos protein immunoreactivity in the rat forebrain is not mimicked by the addition of alpha 1-adrenergic or 5-HT2 receptor blockage to haloperidol. Neurosci. Lett, 194, 77-80.
21. Gerfen, C.R. (1992) The neostriatal mosaic: Multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci., 15, 285-320.
22. Graybiel, A.M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci., 13, 244-254.
23. Graybiel, A.M. & Ragsdale, C.W. Jr (1978) Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc. Natl. Acad. Sci. USA, 75, 5723-5726.
24. Green, M.F. & Braff, D.L. (2001) Translating the basic and clinical cognitive neuroscience of schizophrenia to development and clinical trials of antipsychotic medications. Biol. Psychiatry, 49, 374-384.
25. Guo, N., Robertson, G.S. & Fibiger, H.C. (1992) Scopolamine attenuates haloperidol-induced c-fos expression in the striatum. Brain Res., 588, 164-167.
26. Hall, H., Ogren, S.O., Kohler, C. & Magnusson, O. (1989) Animal pharmacology of raclopride, a selective dopamine D2 antagonist. Psychopharmacol. Ser., 7, 123-130.
27. Herkenham, M. & Pert, C.B. (1981) Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature, 291, 415-418.
28. Hiroi, N. & Graybiel, A.M. (1996) Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol., 374, 70-83.
29. Jakab, R.L., Hazrati, L.N. & Goldman-Rakic, P. (1996) Distribution and neurochemical character of substance P receptor (SPR) - Immunoreactive striatal neurons of the macaque monkey: accumulation of SP fibers and SPR neurons and dendrites in 'striocapsules' encircling striosomes. J. Comp. Neurol., 369, 137-149.
30. Kawaguchi, Y., Wilson, C.J. & Emson, P.C. (1989) Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J. Neurophysiol., 62, 1052-1068.
31. Leveque, J.C., Macias, W., Rajadhyaksha, A., Carlson, R.R., Barczak, A., Kang, S., Li, X.M., Coyle, J.T., Huganir, R.L., eckers, S. & Konradi, C. (2000) Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci., 20, 4011-4020.
32. Ljungberg, T. & Ungerstedt, U. (1979) Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency. Psychopharmacology (Berl), 60, 303-307.
33. Meltzer, H.Y., Chai, B.L., Thompson, P.A. & Yamamoto, B.K. (1994) Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine. J. Pharmacol. Exp. Ther., 268, 1452-1461.
34. Meltzer, H.Y. & McGurk, S.R. (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schiz. Bull., 25, 233-255.
35. Meltzer, H.Y., Park, S. & Kessler, R. (1999) Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc. Natl. Acad. Sci. USA, 96, 13591-13593.
36. Moratalla, R., Quinn, B., DeLanney, L.E., Irwin, I., Langston, J.W. & Graybiel, A.M. (1992) Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA, 89, 3859-3863.
37. Newman-Tancredi, A., Gavaudan, S., Conte, C., Chaput, C., Touzard, M., Verriele, L., Audinot, V. & Millan, M.J. (1998) Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: A [35S]GTPgammaS binding study. Eur. J. Pharmacol., 355, 245-256.
38. Nguyen, T.V., Kosofsky, B.E., Birnbaum, R., Cohen, B.M. & Hyman, S.E. (1992) Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl. Acad. Sci. USA, 89, 4270-4274.
39. Nordstrom, A.L., Farde, L., Wiesel, F.A., Forslund, K., Pauli, S., Halldin, C. & Uppfeldt, G. (1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients. Biol. Psychiatry, 33, 227-235.
40. Olson, L., Seiger, A. & Fuxe, K. (1972) Heterogeneity of striatal and limbic dopamine innervation: Highly fluorescent islands in developing and adult rats. Brain Res., 44, 283-288.
41. Osborne, P.G., O'Connor, W.T., Beck, O. & Ungerstedt, U. (1994) Acute vs chronic haloperidol: Relationship between tolerance to catalepsy and striatal and accumbens dopamine, GABA, and acetylcholine release. Brain Res., 634, 20-30.
42. Paxinos, G. & Watson, C. (1986). The Rat Brain in Stereotaxic Coordinates, (2nd Edn). Academic Press, San Diego.
43. Peacock, L. & Gerlach, J. (1996) Antipsychotic-induced side effects related to receptor affinity. In Csernansky, J.G. (ed.), Antipsychotics. Springer, Berlin, pp. 359-388.
44. Penny, G.R., Wilson, C.J. & Kitai, S.T. (1988) Relationship of the axonal and dendritic geometry of spiny projection neurons to the compartmental organization of the neostriatum. J. Comp. Neurol., 269, 275-289.
45. Poewe, W. & Luginger, E. (1999) Depression in Parkinson's disease: Impediments to recognition and treatment options. Neurology, 52, S2-S6.
46. Prensa, L., Gimenez-Amaya, J.M. & Parent, A. (1999) Chemical heterogeneity of the striosomal compartment in the human striatum. J. Comp. Neurol., 413, 603-618.
47. Robertson, G.S. & Fibiger, H.C. (1992) Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine. Neuroscience, 46, 315-328.
48. Roth, B.L., Craigo, S.C., Choudhary, M.S., Uluer, A., Monsma, F.J., Shen, Y., Meltzer, H.Y. & Sibley, D.R. (1994) Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 268, 1403-1410.
49. Schotte, A., Janssen, P.F., Gommeren, W., Luyten, W.H., Van Gompel, P., De Lesage, A.S., Loore, K. & Leysen, J.E. (1996) Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding. Psychopharmacology (Berl), 124, 57-73.
50. Schotte, A., Janssen, P.F., Megens, A.A. & Leysen, J.E. (1993) Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res., 631, 191-202.
51. Svenningsson, P., Fredholm, B.B., Bloch, B. & Le Moine, C. (2000) Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons. Neuroscience, 98, 749-757.
52. Tremblay, P.O., Gervais, J. & Rouillard, C. (1998) Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists. Eur. J. Neurosci., 10, 3546-3555.
53. White, N.M. (1989) A functional hypothesis concerning the striatal matrix and patches: Mediation of S-R memory and reward. Life Sci., 45, 1943-1957.
54. White, N.M. & Hiroi, N. (1998) Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl. Acad. Sci. USA, 95 , 6486-6491.
55. Zeng, X.P., Le, F. & Richelson, E. (1997) Muscarinic m4 receptor activation by some atypical antipsychotic drugs. Eur. J. Pharmacol., 321, 349-354.
56. Zhang, W. & Bymaster, F.P. (1999) The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology (Berl), 141, 267-278.
57. Zorn, S.H., Jones, S.B., Ward, K.M. & Liston, D.R. (1994) Clozapine is a potent and selective muscarinic M4 receptor agonist. Eur. J. Pharmacol., 269, R1-R2.